These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9678294)

  • 1. Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal women.
    Al-Khalili F; Eriksson M; Landgren BM; Schenck-Gustafsson K
    Am J Cardiol; 1998 Jul; 82(2):215-8. PubMed ID: 9678294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
    Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
    J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women.
    Lieberman EH; Gerhard MD; Uehata A; Walsh BW; Selwyn AP; Ganz P; Yeung AC; Creager MA
    Ann Intern Med; 1994 Dec; 121(12):936-41. PubMed ID: 7978718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
    Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid profiles and endothelial function with low-dose hormone replacement therapy in postmenopausal women at risk for coronary artery disease: a randomized trial.
    Mercuro G; Vitale C; Fini M; Zoncu S; Leonardo F; Rosano GM
    Int J Cardiol; 2003 Jun; 89(2-3):257-65. PubMed ID: 12767550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women.
    Gerhard M; Walsh BW; Tawakol A; Haley EA; Creager SJ; Seely EW; Ganz P; Creager MA
    Circulation; 1998 Sep; 98(12):1158-63. PubMed ID: 9743505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease.
    Yeboah J; Reboussin DM; Waters D; Kowalchuk G; Herrington DM
    Am Heart J; 2007 Mar; 153(3):439-44. PubMed ID: 17307425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women.
    Wakatsuki A; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):571-6. PubMed ID: 14699021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effect of estrogen on metabolic coronary vasodilator responses to atrial pacing in postmenopausal women.
    Anderson TJ
    Am J Cardiol; 1998 Jul; 82(2):236-9. PubMed ID: 9678297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen therapy increases plasma concentrations of nitric oxide metabolites in postmenopausal women but increases flow-mediated vasodilation only in younger women.
    López-Jaramillo P; Díaz LA; Pardo A; Parra G; Jaimes H; Chaudhuri G
    Fertil Steril; 2004 Dec; 82(6):1550-5. PubMed ID: 15589858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of baseline forearm vasodilator reserve to vascular endothelial response to estrogen replacement therapy in healthy postmenopausal women.
    Ilercil A; Freeman R; Lachmann J; Brofferio A; Scotton M; Lekaj P; Freitag A; Emerson M; LeJemtel TH; Shirani J
    Am J Cardiol; 2002 May; 89(9):1139-41. PubMed ID: 11988212
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk.
    Cerquetani E; Vitale C; Mercuro G; Fini M; Zoncu S; Rosano GM
    Gynecol Endocrinol; 2004 Jun; 18(6):291-8. PubMed ID: 15497491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women.
    Blum A; Hathaway L; Mincemoyer R; Schenke WH; Kirby M; Csako G; Waclawiw MA; Panza JA; Cannon RO
    J Am Coll Cardiol; 2000 Feb; 35(2):271-6. PubMed ID: 10676669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women.
    Kawano H; Motoyama T; Hirai N; Yoshimura T; Kugiyama K; Ogawa H; Okamura H; Yasue H
    Am J Cardiol; 2001 Jan; 87(2):238-40, A9. PubMed ID: 11152852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
    Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
    Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
    Silvestri A; Gambacciani M; Vitale C; Monteleone P; Ciaponi M; Fini M; Genazzani AR; Mercuro G; Rosano GM
    Maturitas; 2005 Apr; 50(4):305-11. PubMed ID: 15780531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen.
    Worboys S; Kotsopoulos D; Teede H; McGrath B; Davis SR
    J Clin Endocrinol Metab; 2001 Jan; 86(1):158-61. PubMed ID: 11231994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon.
    Lekakis J; Mavrikakis M; Papamichael C; Papazoglou S; Economou O; Scotiniotis I; Stamatelopoulos K; Vemmos C; Stamatelopoulos S; Moulopoulos S
    Am Heart J; 1998 Nov; 136(5):905-12. PubMed ID: 9812087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term estrogen therapy on brachial arterial endothelium-dependent vasodilation in women with Raynaud's phenomenon secondary to systemic sclerosis.
    Lekakis J; Papamichael C; Mavrikakis M; Voutsas A; Stamatelopoulos S
    Am J Cardiol; 1998 Dec; 82(12):1555-7, A8. PubMed ID: 9874070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.